Literature DB >> 26142603

National Patterns of Urethral Evaluation and Risk Factors for Urethral Injury in Patients With Penile Fracture.

Joseph J Pariser1, Shane M Pearce2, Sanjay G Patel2, Gregory T Bales2.   

Abstract

OBJECTIVE: To examine the epidemiology and timing of penile fracture, patterns of urethral evaluation, and risk factors for concomitant urethral injury.
MATERIALS AND METHODS: The National Inpatient Sample (2003-2011) was used to identify patients with penile fractures. Clinical data included age, race, comorbidity, insurance, hospital factors, timing, hematuria, and urinary symptoms. Rates of formal urethral evaluation (cystoscopy or urethrogram) and urethral injury were calculated. Multivariate logistic regression was used to identify predictors of urethral evaluation and risk factors for urethral injury.
RESULTS: A weighted population of 3883 patients with penile fracture was identified. Presentations during weekends (37%) and summers (30%) were overrepresented (both P <.001). Urethral evaluation was performed in 882 patients (23%). Urethral injury was diagnosed in 813 patients (21%) with penile fracture. There was an increased odds of urethral evaluation with hematuria (odds ratio [OR] = 2.99; 95% confidence interval [CI], 1.03-8.73; P = .045) and a decrease for Hispanics (OR = 0.42; 95% CI, 0.22-0.82; P = .011). Older age (32-41 years: OR = 1.84; 95% CI, 1.07-3.16; P = .027; >41 years: OR = 2.25; 95% CI, 1.25-4.05; P = .007), black race (OR = 1.93; 95% CI, 1.12-3.34; P = .018), and hematuria (OR = 17.03; 95% CI, 3.20-90.54; P = .001) were independent risk factors for urethral injury.
CONCLUSION: Penile fractures, which occur disproportionately during summer and weekends, were associated with a 21% risk of urethral injury. Urethral evaluations were performed in a minority of patients. Even in patients with hematuria, 55% of patients underwent formal urethral evaluation. On multivariate analysis of patients with penile fracture, hematuria as well as older age and black race were independently associated with concomitant urethral injury.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26142603     DOI: 10.1016/j.urology.2015.03.039

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  7 in total

1.  Male genital trauma at a level 1 trauma center.

Authors:  Connor S McCormick; Mitchell G Dumais; Niels V Johnsen; Bryan B Voelzke; Judith C Hagedorn
Journal:  World J Urol       Date:  2020-02-20       Impact factor: 4.226

Review 2.  Management of penile fracture.

Authors:  Jesse Ory; Greg Bailly
Journal:  Can Urol Assoc J       Date:  2019-06       Impact factor: 1.862

Review 3.  Injury to the male external genitalia: a comprehensive review.

Authors:  James Furr; Daniel Culkin
Journal:  Int Urol Nephrol       Date:  2017-02-08       Impact factor: 2.370

4.  An update of Penile Fractures: Long-term significance of the number of hours elapsed till surgical repair on long-term outcomes.

Authors:  Zafer Kozacıoğlu; Yasin Ceylan; Özgü Aydoğdu; Deniz Bolat; Bülent Günlüsoy; Süleyman Minareci
Journal:  Turk J Urol       Date:  2017-01-06

Review 5.  Imaging spectrum of traumatic urinary bladder and urethral injuries.

Authors:  Sirote Wongwaisayawan; Satheesh Krishna; Adnan Sheikh; Rathachai Kaewlai; Nicola Schieda
Journal:  Abdom Radiol (NY)       Date:  2020-07-28

6.  Older age and a large tunical tear may be predictors of increased erectile dysfunction rates following penile fracture surgery.

Authors:  Mazhar Ortac; Faruk Özgor; Ufuk Caglar; Abdullah Esmeray; Metin Savun; Ömer Sarılar
Journal:  Int J Impot Res       Date:  2019-06-05       Impact factor: 2.896

7.  Risk factors for penile fracture compared with a surgical control cohort in the United States: the role of substance abuse.

Authors:  Nathaniel Christian-Miller; Andrew T Lenis; Katherine E Fero; Josef Madrigral; Sriram V Eleswarapu; Karim Chamie; Peyman Benharash
Journal:  Asian J Androl       Date:  2021 May-Jun       Impact factor: 3.285

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.